Sale of Securities

Vaxcyte, Inc. Filed 2026-10-01 Acc 0001969223-26-001049

Documents 1

2026-10-06 305B2 305B2
2026-10-05 144 Sale of Securities
2026-10-05 144 Sale of Securities
2026-10-05 8-K Regulation FD disclosure · Other events
2026-10-02 4 EVP, Chief Scientific Ofc, COO sold 2,250 shares at an average $56.67 ($127,513)
2026-10-01 144 Sale of Securities
2026-09-09 144 Sale of Securities

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…